Chiho Nakashima

402 citations
24 papers · 278 indexed · h-index 10
Topics
Lung Cancer Treatments and Mutations (12 papers)Cancer Genomics and Diagnostics (8 papers)Cancer Immunotherapy and Biomarkers (4 papers)
Partner nations
JapanGreece

In The Last Decade

Chiho Nakashima

22 papers receiving 269 citations

Peers

Chiho Nakashima
Comparison fields: 5 of 60
  • Oncology 140
  • Pulmonary and Respiratory Medicine 107
  • Molecular Biology 99
  • Cancer Research 77
  • Pathology and Forensic Medicine 25
Replace Dan He with:
Dan He China
Tsutomu Imanishi Japan
Yiran Cai China
Eiji Osaka Japan
Jinzhong Duanmu China
Lorenz Jost Switzerland
Kang Qin China
Chris Nevala-Plagemann United States
Niek A. Peters Netherlands
Aiko Nagayama Japan
Chiho Nakashima relative to Dan He China Dan He's profile →
Citations per field
00.5×
Dan He · 1×
Citations per year

Countries citing papers authored by Chiho Nakashima

Since Specialization
Citations

This map shows the geographic impact of Chiho Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiho Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiho Nakashima more than expected).

Fields of papers citing papers by Chiho Nakashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiho Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiho Nakashima. The network helps show where Chiho Nakashima may publish in the future.

Co-authorship network of co-authors of Chiho Nakashima

This figure shows the co-authorship network connecting the top 25 collaborators of Chiho Nakashima. A scholar is included among the top collaborators of Chiho Nakashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiho Nakashima. Chiho Nakashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 10
4 6
5 5
6 6
7 8
8 6
9 12
10 5
11 0
12 6
13 31
14 9
15 1
16 23
17 6
18 11
19 9
20 43

About Chiho Nakashima

Chiho Nakashima is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 24 papers that have together received 278 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Oncology (140 citations), Cancer Research (77 citations) and Pulmonary and Respiratory Medicine (107 citations). Chiho Nakashima has collaborated with scholars based in Japan and Greece. Frequent co-authors include Naoko Sueoka‐Aragane, Shinya Kimura, Tomomi Nakamura, Kazutoshi Komiya, Koichiro Takahashi, Akemi Sato, Mitsuharu Hirai, Eisaburo Sueoka, Yuji Takeda and Junichi Kato. Their work appears in journals such as PLoS ONE, Cancer Research and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026